Overview

Air disinfection technology is called LEA™ and is based on an electrokinetic system with large area electrode arrays which are able to inactivate Airborne pathogens and particles down to the size of atoms without producing any harmful byproducts like Ozone or NOx. byproducts. 

 

Scope of Work

• CleanAir systems with LEA™ air disinfection already got tested in the U.S. at an independent FDA-certified testing laboratory which confirms that LEA™ air disinfection technology provides an unrivaled 99.99992% reduction rate of airborne bioaerosols such as viruses, bacteria and other pathogens from the without any measurable harmful

​

Technology Stack

• Innovation High Voltage technology, unique industrial design, mechanical design, CE/FDA submission, preparation DMR and DHF. Validation/Verification tests. Device marketing for EU and US market 

​

Outcome

• A positive outcome of the CleanAir project will result in a powerful air purification and disinfection device that will be used primarily for the protection of medical staff and patients in medical facilities such as hospitals and other medical institutions​